Phaarmasia Ltd

Phaarmasia Ltd has surged to a fresh 52-week high of Rs.129.2, reflecting a robust rally that has propelled the stock to outperform its sector and demonstrate sustained upward momentum over the past fortnight.

Phaarmasia Ltd has surged to a fresh 52-week high of Rs.126.7, reflecting a robust rally that has propelled the stock to outperform its sector and demonstrate sustained upward momentum over the past several trading sessions.

Phaarmasia Ltd has reached a significant milestone by hitting a new 52-week high of Rs.122.2 today, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. This achievement comes after a sustained rally, with the stock gaining 15.01% over the past eight consecutive trading sessions.

Phaarmasia Ltd has surged to a fresh 52-week high of Rs.121.85, reflecting a robust rally that has propelled the stock to outperform its sector and demonstrate sustained upward momentum over the past week.

Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 06 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Phaarmasia Ltd surged to a fresh 52-week high of Rs.119.5 on 5 Jan 2026, reflecting robust upward momentum in the Pharmaceuticals & Biotechnology sector. The stock has demonstrated sustained gains over the past week, outperforming its sector peers and trading well above key moving averages.

Phaarmasia Ltd has surged to a fresh 52-week high of Rs.117.2, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. This milestone underscores the stock’s impressive rally, driven by sustained gains and favourable market conditions.

Phaarmasia Ltd has reached a significant milestone by hitting a new 52-week high of Rs.114.95 today, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. This achievement underscores the stock’s strong performance over the past year, outpacing broader market indices and sector peers.

Phaarmasia Ltd surged to a fresh 52-week high of Rs.112.74 on 31 Dec 2025, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. The stock’s sustained gains over recent sessions underscore a significant rally that has outpaced both its sector peers and the broader market benchmarks.

Phaarmasia Ltd has surged to a fresh 52-week high of Rs.110.53 today, reflecting a robust rally that has propelled the stock well above its recent trading levels. This milestone underscores the company’s sustained upward momentum within the Pharmaceuticals & Biotechnology sector, outpacing broader market trends and sector peers.

Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. While the rating change occurred then, the analysis and financial metrics discussed here reflect the company's current position as of 25 December 2025, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.108.41 today, underscoring a remarkable rally that has captured market attention. This milestone reflects sustained momentum as the stock continues to trade above all major moving averages.

Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.106.29 today, reflecting sustained momentum and a remarkable rally over the past several weeks.

Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, has attained a new 52-week high of Rs.104.21, underscoring a remarkable rally that has captured market attention. This milestone reflects sustained momentum driven by consistent gains over the past three weeks and a notable outperformance relative to its sector peers.

Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.102.17 today, underscoring a remarkable rally that has captured market attention. This milestone reflects sustained momentum driven by consistent gains over the past three weeks and a notable outperformance relative to its sector peers.

Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.100.17 today, underscoring a remarkable rally that has captured market attention. The stock’s sustained upward trajectory over the past three weeks highlights significant momentum within the sector.

Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.98.22 today, underscoring a sustained rally that has captured market attention. The stock’s performance over the past 21 trading sessions reflects a remarkable upward trajectory, significantly outpacing sector benchmarks and broader market indices.

Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.96.3 today, underscoring a sustained rally that has propelled the stock well above its previous levels. This milestone reflects notable momentum in the stock’s performance over recent weeks.

Phaarmasia, a key player in the Pharmaceuticals & Biotechnology sector, reached a fresh 52-week high of Rs.94.42 today, underscoring a remarkable rally that has seen the stock gain over 182% in the past 21 trading sessions.